Jaundice in Babies

What Is Jaundice in Babies?

Neonatal jaundice occurs when a newborn’s liver is not yet mature enough to efficiently filter bilirubin, a yellow pigment produced during normal red blood cell breakdown, from the bloodstream.¹

This immaturity leads to bilirubin buildup, causing the characteristic yellowing of the skin and eyes recognized as jaundice in newborns.¹

While often mild and temporary, excessive bilirubin in the blood, known as hyperbilirubinemia, can potentially cause brain damage if left unrecognized and untreated.¹

Neonatal jaundice occurs when newborns’ livers are not mature enough to filter out bilirubin, and excessive bilirubin in the blood may cause brain damage and death.
National Center for Biotechnology Information

Symptoms

The primary visible symptom of neonatal jaundice is yellowing of the skin and the whites of the eyes, typically becoming noticeable within the first few days after birth.

Jaundice often begins on the face and, as bilirubin levels rise, can progressively spread downward toward the chest, abdomen, and legs.

In more severe cases, additional symptoms such as poor feeding, excessive sleepiness, or high pitched crying may develop, signaling the need for prompt medical evaluation.

Causes

Common causes of severe neonatal jaundice include hemolysis, meaning red blood cell breakdown, related to Rh factor or ABO blood group incompatibility between mother and baby.¹

Glucose-6-phosphate dehydrogenase deficiency and other hemolytic disorders represent additional important causes, alongside factors such as premature birth, infection, and localized bleeding under the scalp called cephalohematoma.¹

Breastfeeding related jaundice can also occur, sometimes related to insufficient milk intake in the first days of life rather than any problem with breast milk itself.¹

Risk Factors

Premature birth represents a significant risk factor, since preterm infants have even less mature liver function compared to full term newborns.¹

Blood type incompatibility between mother and baby, along with certain inherited enzyme deficiencies, meaningfully increase the risk of more severe jaundice requiring treatment.¹

Difficulty establishing effective breastfeeding in the first days of life can also contribute to higher bilirubin levels, making early feeding support an important preventive consideration.¹

Complications

Phototherapy is used specifically to prevent the neurotoxic, or brain damaging, effects that can result from excessive bilirubin accumulation in newborns.²

Without appropriate monitoring and treatment, severely elevated bilirubin levels carry risk of causing lasting neurological damage, underscoring the importance of timely identification and intervention.¹

Ongoing research continues to investigate the specific neuroinflammatory effects of bilirubin breakdown products, further informing understanding of why prompt treatment matters so much.³

Treatment

Phototherapy represents the standard treatment for neonatal hyperbilirubinemia, working by converting bilirubin into more water soluble compounds that the body can excrete more easily.¹

The specific phototherapy dose delivered depends on several factors, including the light’s wavelength, intensity, distance from the infant, and the total body surface area exposed to treatment.⁴

Commercially available phototherapy systems include those using fluorescent bulbs, halogen quartz lamps, light emitting diodes, and specialized fiberoptic mattresses, each offering slightly different delivery approaches.⁴

Prevention

Ensuring effective early breastfeeding support can help reduce the risk of jaundice related to insufficient early milk intake.¹

Routine newborn screening for jaundice, including visual assessment and bilirubin testing when indicated, supports early identification before levels become concerning.

For infants with known risk factors, such as blood type incompatibility, closer monitoring in the days following birth supports earlier intervention if bilirubin levels begin rising significantly.¹

Why Visual Communication Matters for Jaundice in Babies

Explaining how phototherapy works to break down bilirubin at a molecular level requires visuals that make this treatment reassuring and understandable for anxious new parents.

Pharmaceutical companies, pediatric practices, and patient education organizations rely on clear illustration and animation to explain neonatal jaundice causes and treatment.

• Illustrating bilirubin production and liver processing in newborns
• Animating the mechanism of action of phototherapy treatment
• Explaining causes including blood type incompatibility and prematurity
• Visualizing typical jaundice progression patterns
• Supporting patient education on when to seek medical evaluation
• Creating training materials for pediatric and neonatal clinicians

How Biotic Artlab Supports Jaundice in Babies Communication

We work with pharmaceutical companies, pediatric practices, and healthcare organizations to create scientifically accurate visuals that make neonatal jaundice easier to understand.

• Custom 3D animations of bilirubin metabolism and liver function
• Detailed illustrations of phototherapy treatment mechanisms
• Visualizations of jaundice progression and severity assessment
• Patient facing materials on symptom recognition and when to seek care
• Clinical training content for pediatric and neonatal teams
• Conference presentations and marketing visuals for newborn health audiences

Frequently Asked Questions

What causes jaundice in newborns?

An immature liver is unable to efficiently filter bilirubin, leading to its buildup and characteristic yellowing.¹

Is neonatal jaundice dangerous?

Mild jaundice is common and often resolves on its own, but severe untreated cases can potentially cause brain damage.¹

What is phototherapy?

It is the standard treatment for neonatal jaundice, using light to convert bilirubin into forms the body can excrete more easily.¹

What increases a baby’s risk of severe jaundice?

Prematurity, blood type incompatibility, and certain enzyme deficiencies increase risk.¹

Can breastfeeding cause jaundice?

Insufficient early milk intake can contribute to jaundice, though it is generally manageable with proper feeding support.¹

How is phototherapy dosing determined?

It depends on light wavelength, intensity, distance from the baby, and body surface area exposed.⁴

Have a Project in Mind? Contact Us.

If you are developing patient education materials, clinical training content, or marketing visuals related to neonatal jaundice, our team can help translate the science into visuals that are both accurate and easy to understand. Contact us at info@biotic-artlab.com or get in touch through our contact form to discuss your project.

References

1. National Center for Biotechnology Information. Neonatal Hyperbilirubinemia Treatment by Locally Made Low-Cost Phototherapy Units.
2. National Center for Biotechnology Information. Fundamentals of Phototherapy for Neonatal Jaundice.
3. National Center for Biotechnology Information. Neuro-inflammatory Effects of Photodegradative Products of Bilirubin.
4. National Center for Biotechnology Information. Phototherapy for Neonatal Jaundice, Therapeutic Effects on More Than One Level.

Disclaimer: This page provides general educational information and is not a substitute for diagnosis, treatment, or individualized advice from a qualified healthcare professional.